118 related articles for article (PubMed ID: 38062971)
1. [Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A].
Murtadha AH; Sharudin NA; Azahar IIM; Che Has AT; Mokhtar NF
Mol Biol (Mosk); 2023; 57(6):21-30. PubMed ID: 38062971
[TBL] [Abstract][Full Text] [Related]
2. Influence of nNav1.5 on MHC class I expression in breast cancer.
Murtadha AH; Azahar IIM; Sharudin NA; Che Has AT; Mokhtar NF
J Biosci; 2021; 46():. PubMed ID: 34313250
[TBL] [Abstract][Full Text] [Related]
3. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Manning J; Indrova M; Lubyova B; Pribylova H; Bieblova J; Hejnar J; Simova J; Jandlova T; Bubenik J; Reinis M
Immunology; 2008 Feb; 123(2):218-27. PubMed ID: 17725605
[TBL] [Abstract][Full Text] [Related]
4. The role of REST and HDAC2 in epigenetic dysregulation of Nav1.5 and nNav1.5 expression in breast cancer.
Kamarulzaman NS; Dewadas HD; Leow CY; Yaacob NS; Mokhtar NF
Cancer Cell Int; 2017; 17():74. PubMed ID: 28785170
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.
Vlková V; Štěpánek I; Hrušková V; Šenigl F; Mayerová V; Šrámek M; Šímová J; Bieblová J; Indrová M; Hejhal T; Dérian N; Klatzmann D; Six A; Reiniš M
Oncotarget; 2014 Aug; 5(16):6923-35. PubMed ID: 25071011
[TBL] [Abstract][Full Text] [Related]
7. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K; Colbert JD; Rock KL
Front Immunol; 2021; 12():636568. PubMed ID: 33767702
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
10. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
11. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.
Setiadi AF; Omilusik K; David MD; Seipp RP; Hartikainen J; Gopaul R; Choi KB; Jefferies WA
Cancer Res; 2008 Dec; 68(23):9601-7. PubMed ID: 19047136
[TBL] [Abstract][Full Text] [Related]
13. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
Chou SD; Khan AN; Magner WJ; Tomasi TB
Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
Imanishi T; Kamigaki T; Nakamura T; Hayashi S; Yasuda T; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Kobe J Med Sci; 2006; 52(3-4):85-95. PubMed ID: 16855371
[TBL] [Abstract][Full Text] [Related]
15. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
16. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing.
Liang YH; Tsai JH; Cheng YM; Chan KY; Hsu WL; Lee CC; Chen KH; Yeh KH
Sci Rep; 2021 Apr; 11(1):9080. PubMed ID: 33907276
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
[TBL] [Abstract][Full Text] [Related]
19. Invasion and Metastasis Suppression by Anti-Neonatal Nav1.5 Antibodies in Breast Cancer.
Sharudin NA; Murtadha Noor Din AH; Azahar II; Mohd Azlan M; Yaacob NS; Sarmiento ME; Dominguez AA; Mokhtar NF
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2953-2964. PubMed ID: 36172657
[TBL] [Abstract][Full Text] [Related]
20. The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.
Seliger B
J Immunotoxicol; 2014 Oct; 11(4):308-10. PubMed ID: 24479372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]